205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-6.23%
Negative revenue growth while Technology median is -3.39%. Seth Klarman would investigate if the company is losing market share or facing a declining industry.
-7.26%
Negative gross profit growth while Technology median is -2.15%. Seth Klarman would suspect poor product pricing or inefficient production.
-9.56%
Negative EBIT growth while Technology median is 0.00%. Seth Klarman would check if external or internal factors caused the decline.
-11.12%
Negative operating income growth while Technology median is -2.61%. Seth Klarman would check if structural or cyclical issues are at play.
-12.95%
Negative net income growth while Technology median is -1.44%. Seth Klarman would investigate factors dragging net income down.
-12.96%
Negative EPS growth while Technology median is 0.00%. Seth Klarman would explore whether share dilution or profit declines are to blame.
-13.15%
Negative diluted EPS growth while Technology median is 0.00%. Seth Klarman would look for the cause: weakened profitability or heavier share issuance.
0.11%
Share change of 0.11% while Technology median is zero. Walter Schloss would see if the modest difference matters long-term.
No Data
No Data available this quarter, please select a different quarter.
0.07%
Dividend growth of 0.07% while Technology median is flat. Walter Schloss might appreciate at least a modest improvement.
-43.19%
Negative OCF growth while Technology median is -5.81%. Seth Klarman would ask if accounting or macro issues hamper the firm specifically.
-83.44%
Negative FCF growth while Technology median is -4.20%. Seth Klarman would see if others in the industry are still generating positive expansions in free cash.
85.25%
10Y revenue/share CAGR exceeding 1.5x Technology median of 32.22%. Joel Greenblatt would verify if a unique moat or brand fosters outperformance over a decade.
25.26%
5Y revenue/share growth 1.25-1.5x Technology median of 20.02%. Mohnish Pabrai might attribute the outperformance to scale or brand strength.
35.02%
3Y revenue/share growth exceeding 1.5x Technology median of 19.93%. Joel Greenblatt might see a short-term competitive advantage at play.
293.27%
OCF/share CAGR of 293.27% while Technology median is zero. Walter Schloss might see a modest edge that can add up if momentum improves.
13.06%
OCF/share CAGR of 13.06% while Technology median is zero. Walter Schloss might see a slight advantage that can compound if momentum builds.
39.92%
3Y OCF/share growth of 39.92% while Technology median is zero. Walter Schloss might see a modest advantage that could compound if momentum holds.
475.86%
Net income/share CAGR exceeding 1.5x Technology median of 16.60% over a decade. Joel Greenblatt might see a standout compounder of earnings.
35.51%
5Y net income/share CAGR > 1.5x Technology median of 4.58%. Joel Greenblatt might see superior mid-term capital allocation or product strength.
49.34%
3Y net income/share CAGR > 1.5x Technology median of 14.35%. Joel Greenblatt might see a recent surge from market share gains or cost synergy.
69.87%
Equity/share CAGR exceeding 1.5x Technology median of 38.23% over 10 years. Joel Greenblatt would see if a high ROE underlies this compounding advantage.
55.24%
5Y equity/share CAGR > 1.5x Technology median of 21.60%. Joel Greenblatt sees a possible ROE advantage or fewer share issuances boosting book value.
102.31%
3Y equity/share CAGR > 1.5x Technology median of 18.27%. Joel Greenblatt sees strong short-term returns on equity fueling net worth growth.
491.84%
Dividend/share CAGR of 491.84% while Technology is zero. Walter Schloss sees a minor improvement that could compound if the firm maintains consistent raises.
99.55%
5Y dividend/share CAGR of 99.55% while Technology is zero. Walter Schloss sees at least some improvement that could compound over time.
37.31%
3Y dividend/share CAGR of 37.31% while Technology is zero. Walter Schloss sees a slight advantage if the firm is at least inching up payouts.
-0.95%
AR shrinking while Technology median grows. Seth Klarman sees potential advantage unless it signals declining demand.
19.26%
Inventory growth of 19.26% while Technology median is zero. Walter Schloss checks if we’re preparing for a sales push or risking overstock.
7.40%
We expand assets while Technology is negative. Peter Lynch sees a possible advantage if expansions align with profitable markets or a recovering cycle.
4.45%
BV/share growth of 4.45% while Technology is zero. Walter Schloss sees a slight lead that can expand if sustained over time.
11.53%
Slightly rising debt while Technology median is deleveraging. Peter Lynch wonders if the firm lags behind peers in risk control or invests in more expansions.
4.84%
R&D growth of 4.84% while Technology median is zero. Walter Schloss wonders if a slight increase yields a meaningful competitive edge.
10.49%
SG&A growth of 10.49% while Technology median is zero. Walter Schloss sees a modest overhead increase needing revenue justification.